Nephrotic syndrome: Don't forget the bones! (Editorial)
GRAHAME J ELDER,
GRAHAME J ELDER
Centre for Transplant and Renal Research,Westmead Millennium Institute and the Bone and Mineral Program,Garvan Institute of Medical Research,Sydney, New South Wales, Australia
Search for more papers by this authorGRAHAME J ELDER,
GRAHAME J ELDER
Centre for Transplant and Renal Research,Westmead Millennium Institute and the Bone and Mineral Program,Garvan Institute of Medical Research,Sydney, New South Wales, Australia
Search for more papers by this authorNo abstract is available for this article.
REFERENCES
- 1 Cranney A, Horsley T, O'Donnell S et al. Effectiveness and Safety of Vitamin D in Relation to Bone Health. AHRQ Publication no. 07-E013. (Evidence Report/Technology Assessment no. 158). Rockville: Agency for Healthcare Research and Quality, 2007.
- 2 Elder GJ. Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology (Carlton) 2007; 12: 90–94.
- 3 Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007; 72: 1004–13.
- 4 Van Hoof HJ, De Sevaux RG, Van Baelen H et al. Relationship between free and total 1,25-dihydroxyvitamin D in conditions of modified binding. Eur J. Endocrinol. 2001; 144: 391–6.
- 5 Elder GJ, Mackun K. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J. Bone Miner. Res. 2006; 21: 1778–84.
- 6 Hayden JM, Mohan S, Baylink DJ. The insulin-like growth factor system and the coupling of formation to resorption. Bone 1995; 17 (Suppl 2): 93S–8S.
- 7 Wawrzynska L, Tomkowski WZ, Przedlacki J et al. Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism. Pathophysiol. Haemost. Thromb. 2003; 33: 64–7.
- 8 Bak M, Serdaroglu E, Guclu R. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr. Nephrol. 2006; 21: 350–54.
- 9 Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N. Engl. J. Med. 1993; 328: 1747–52.
- 10 Palmer SC, Strippoli GF, McGregor DO. Interventions for preventing bone disease in kidney transplant recipients: A systematic review of randomized controlled trials. Am. J. Kidney Dis. 2005; 45: 638–49.
- 11 Sambrook PN, Kotowicz M, Nash P et al. Prevention and treatment of glucocorticoid-induced osteoporosis: A comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J. Bone Miner. Res. 2003; 18: 919–24.
- 12 Kim SD, Cho BS. Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy. Nephron Clin. Pract. 2006; 102: c81–7.
Citing Literature
